NJR ‘Who benefits’ series of articles

The third and final article in our NJR stakeholder benefits series in the Journal of Trauma and Orthopaedics is now online.

In this final part of the ‘Who benefits?’ series, we outline the benefits of the NJR to service commissioners, regulators and policymakers and to broader society through our research and innovation work.

These benefits include quality improvement, cost-effectiveness and value for money, continuous surveillance for implant safety, and our active participation in the broader healthcare community.

You can find it herehttps://www.boa.ac.uk/resource/jto-march-2024.html

Or click here for our sharable excerpt

  •  
  •  
  •  
  •  
  •  
  •  
Scroll to Top